Insulin pump therapy in transient neonatal diabetes mellitus.
10.6065/apem.2013.18.3.148
- Author:
Joong Heum PARK
1
;
Jeong Hee KANG
;
Kyu Hyung LEE
;
Nam Hyo KIM
;
Han Wook YOO
;
Dae Yeol LEE
;
Eun Gyong YOO
Author Information
1. Department of Pediatrics, CHA University College of Medicine, Seongnam, Korea. pedyoo@cha.ac.kr
- Publication Type:Case Report
- Keywords:
Diabetes mellitus;
Newborn infant;
Insulin infusion systems
- MeSH:
Blood Glucose;
Diabetes Mellitus*;
Female;
Fetal Growth Retardation;
Humans;
Hyperglycemia;
Hypoglycemia;
Infant;
Infant, Newborn;
Insulin Infusion Systems*;
Insulin;
Length of Stay;
Rare Diseases;
Weight Gain
- From:Annals of Pediatric Endocrinology & Metabolism
2013;18(3):148-151
- CountryRepublic of Korea
- Language:English
-
Abstract:
Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia. Although insulin pump therapy is frequently administered to adults and children, there is no consensus on the use of insulin pumps in NDM. A 10 day-old female infant was referred to us with intrauterine growth retardation and poor weight gain. Hyperglycemia was noted, and continuous intravenous insulin infusion was initiated. However, the patient's serum glucose levels fluctuated widely, and maintaining the intravenous route became difficult within the following weeks. Continuous subcutaneous insulin infusion with an insulin pump was introduced on the twenty-fifth day of life, and good glycemic control was achieved without any notable adverse effects including hypoglycemia. We suggest that the insulin pump is a safe and effective mode for treating NDM and its early adoption may shorten the length of hospital stays in patients with NDM.
